Novo Nordisk Drug Outperforms Zepbound in Weight Loss Trial
A new clinical trial shows Novo Nordisk's potential Wegovy successor helped patients lose more weight than Eli Lilly's Zepbound.
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- Novo Nordisk
- Wegovy
- Zepbound